Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model

Transplant Proc. 1993 Apr;25(2):2077-9.
No abstract available

MeSH terms

  • Animals
  • Arteriosclerosis / chemically induced
  • Arteriosclerosis / prevention & control*
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Cholesterol, VLDL / blood
  • Creatinine / blood
  • Graft Survival / drug effects
  • Heart Transplantation / immunology
  • Heart Transplantation / pathology*
  • Heart Transplantation / physiology
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Lovastatin / analogs & derivatives*
  • Lovastatin / therapeutic use
  • Rats
  • Rats, Inbred BN
  • Rats, Inbred Lew
  • Simvastatin
  • Tacrolimus / therapeutic use
  • Tacrolimus / toxicity*
  • Transplantation, Homologous
  • Transplantation, Isogeneic

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Cholesterol, VLDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Cholesterol
  • Lovastatin
  • Simvastatin
  • Creatinine
  • Tacrolimus